)
)
17 Apr 2026
Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial
Artificial intelligence (AI) in healthcare has gained widespread attention, especially in assisting with disease diagnosis, treatment, prognosis, and enhancing clinical decision making.1 The clinical decision support system (CDSS) is an innovative and promising approach for improving stroke outcomes and healthcare services.23 However, the majority of AI applications for stroke healthcare have not been rigorously evaluated through randomised controlled trials. As a result, the use of CDSS in treating cerebrovascular disease is currently limited.